New hope for tough cancers: trial tests drug for patients out of options
Disease control
Recruiting now
This study is testing a new drug called GV20-0251 for adults with advanced solid tumor cancers that have progressed despite standard treatments. The first part aims to find a safe dose, and the second part will see how well the drug works against several types of cancer, includin…
Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC